TickerKhojOpen the scanner

Pharmaceuticals · Pharmaceuticals: Major · NSE: JFLLIFE · data 2026-11-03

JFL Life Sciences Limited

₹10.25+4.59% on 2 NovHealth: Weak 1.7/10

In plain words

Price: 33.4% below its 52-week high of ₹15.4.

A description of the data, not a recommendation.

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price
₹10.25
Market cap
—
P/E
—
P/B
—
ROE
—
ROCE
—
Debt / equity
—
Dividend yield
—
1-year return
-28.8%
52-week high
₹15.4
52-week low
₹8.55
Operating margin
—

Growth

Revenue (last 12 months)—
Net profit (last 12 months)—
Sales growth, 3 years (yearly)—
Profit growth, 3 years (yearly)—

Smart-money activity

5/100 · Weak over the last ~60 sessions

A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.

Common questions

What is the 52-week high and low of JFL Life Sciences Limited?

The 52-week high is ₹15.4 and the 52-week low is ₹8.55.

Compared with similar companies

CompanyPriceMarket capP/EP/BROEROCEDebt/eq.1-yr return
JFL Life Sciences Limited₹10.25——————-28.8%
Medicamen Organics Ltd.₹25.9₹39 cr——-13.7%-15%0.5-23.8%
Medi-Caps Ltd.₹23.46₹30 cr——-2.6%-9.5%0-10.5%
Lasa Supergenerics Ltd.₹4.44₹25 cr——-51.1%-27%0.2-61.3%
Sunrest Lifescience Limited₹37.3₹17 cr4.30.822.4%25.9%0.85-11.2%
Ortin Global Ltd₹13.61₹10 cr——-46.1%-46.3%0.81+18.3%

Compare JFLLIFE with MEDIORG in detail →

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open JFLLIFE in TickerKhoj →
Share on WhatsAppShare on Telegram